ArticleGastroenterology report2022

The efficacy and safety of thalidomide in the treatment of refractory Crohn's disease in adults: a double-center, double-blind, randomized-controlled trial.

Xiang Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.